Shire Press Release Press Release

www.shire.com

Director Share Dealings September 30, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that today Ordinary Shares ("Shares") and American Depository Shares ("ADSs") of the Company, as set out below, have been acquired for the Non-Executive Directors, being the part of their total fees that are paid in shares for the period of service from July 1 to September 30, 2014.

Type of Security (1)

Number of Shares/ADSs

Dominic Blakemore

Shares

98

William Burns

Shares

99

Dr. Steven Gillis

ADSs

32

Dr. David Ginsburg

ADSs

30

David Kappler

Shares

104

Susan Kilsby

ADSs

100

Anne Minto

Shares

104

David Stout

ADSs

32

(1) One ADS is equal to three Shares

The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively at prices of £53.45 per Share and $259.9747 per ADS.
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and
Transparency Rules.
Tony Guthrie
Deputy Company Secretary

For further information please contact:

Investor Relations

Jeff Poulton

jpoulton@shire.com

+1 781 482 0945

Sarah Elton-Farr

seltonfarr@shire.com

+44 1256 894157

Media

Stephanie Fagan

sfagan@shire.com

+1 781 482 0460

Gwen Fisher

gfisher@shire.com

+1 484 595 9836

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
www.shire.com
2

distributed by